CV medicine Flashcards
technical name for a heart attack
myocardial infarction
ACS
angina (+PVD) - ischaemia
MI (+CVA) - infarction
diagnosis of ACS
history
ECG: STEMI, NSTEMI
biomarkers: troponin
atherosclerosis
build up of cholesterol/fats in artery walls
progressive
lose x8 in blood flow
what happens if an atherosclerotic plaque ruptures?
occlusion
stages of progression of atherosclerosis
normal fatty streak plaque increasing plaque obstructive atherosclerotic plaque plaque fissure erosion - thrombosis
why is CAD severe?
no anastomotic supply
angina definition
reversible heart muscle ischaemia
- coronary arteries narrow
classical angina
no pain at rest pain with certain level of exertion (lactic acidosis) - worse with cold weather/emotion pain relieved by rest pt lives within levels of tolerance gradual deterioration
signs of classical angina
often no signs
occ hyperdynamic circulation - anaemia, hyperthyroidism, hypovolaemia
unstable angina
symptoms at rest with no biomarkers
pain with angina
central crushing chest pain
- radiation
- same pain but varies between individuals
angina investigations
ECG - ST segment elevation/depression
angiography
echocardiography
isotope studies
eliminate other disease - thyroid, anaemia, valve
angina tx principles
reduce oxygen demands of heart
increase oxygen delivery to tissues
angina tx - reduce oxygen demands of heart
reduce after load and preload
afterload
bp
preload
venous pressure
effect of sitting up re angina
reduce venous return
reduce CO
angina tx - increase oxygen delivery to tissues
angioplasty - dilate
CABG - bypass
blocked/narrowed vessels
angina non-drug therapy
explain - live within limitations
modify risk factors
angina drug therapy
reduce MI risk - aspirin
hypertension - Ca channel blockers, diuretics, ACE inhibitors, B-blockers
reduce preload/dilate coronary vessels - nitrates
emergency - GTN spray/tab
angina surgery
CABG
angioplasty and stenting (PCI) - gold standard in HA
need anti platelets in both
CABG
bypass blockage in coronary artery that can’t be txed in any other way
can’t redo, mortality risk
PVD
'angina' of the tissues - usually LL atheroma in femoral/popliteal vessels 'claudication' indicates 'arteriopath' - MI risk limitation of fct poor wound healing men and smokers
congestive heart failure
hypertrophy of myocyte but no increase in blood supply
heart weight x2-3 of normal
increased metabolic demands - ischaemia - apoptosis - HF
oedema
cardiac tumours prevalence
rare
benign cardiac tumours
myxoma, lipoma
malignant cardiac tumours
angiosarcoma
what other sources of cardiac tumour?
local extension of tumours from the thoracic cavity e.g. bronchogenic carcinoma
calcific aortic stenosis
commonest valvular condition
dystrophic calcium deposits due to tissue inflammation and hyperlipidaemia
narrowing of valvular orifice
rheumatic heart disease
complication of RF
host immune reaction against strep A antigens
T2 and T4 hypersensitivity reactions
fibrinoid necrosis
thickening and fusion, calcification of valves
risk for IE
why do L valves fail more commonly?
higher pressure
valve stenosis
narrowed opening
types of stenosis and importance
aortic stenosis can lead to heart failure
mitral stenosis not as important
valve incompetence
don’t close properly - backflow
consequence of valvular disease
reduce efficiency of heart as pump - heart failure
symptoms of valvular disease
rarely any symptoms - undiagnosed
valvular issues
stenosis
incompetence
insufficiency
vegetations
causes of valvular disease
common in elderly and Downs congenital MI - papillary muscle rupture RF dilatation of aortic root - syphilis, aneurysm formation
valvular disease investigation
Ultrasound
types of valve replacement
mechanical - metal
porcine
mechanical valve replacement
last longer
anticoagulants
middle age
porcine valve replacement
only last around 10yrs
don’t need anticoagulants
v young - outgrow it, falls
elderly
important principle when choosing valve replacement
few changes as possible - mortality risk
what is there a risk of after valve replacements?
IE
why are CHDs often undetected?
asymptomatic
cyanosis
central
peripheral - cold env
when 5g/dl or more deoxygenated Hb in blood
CHDs investigation
US
types of CHD
ASD (hypertrophy)
VSD
coarctation of aorta (narrowed)
PDA (connects pulmonary artery to aorta)
potential risk of CHDs
IE risk?
IE
microbial infection of endocardium (usually valves)
what is the biggest risk factor for IE?
prev IE
pathogenesis of IE
surface abnormalities haemodynamic changes bacteraemia turbulence platelet/fibrin deposition vegetation microbial attachment and multiplication enlargement
is IE easy to recognise?
no
ABP drug regime
amoxicillin 3g 1hr before
clindamycin 1.5g (higher ADA risk - only use if penicillin allergic)
primary prevention
stop from getting disease
secondary prevention
detect early and prevent progression
aspects of secondary prevention
lifestyle changes
control cholesterol - statin
control hypertension
anti-platelet drugs - aspirin
when should aspirin be used as secondary prevention?
when identified CV disease
when high risk with no identified disease
anticoagulants broad use
if in heart
antiplatelets broad use
if peripheral bvs
irreversible risk factors
- age
- sex
- FH
reversible risk factors
SMOKING
obesity
diet
exercise
reversible genetic risk factors
hypertension
hyperlipidaemia
diabetes
stress?
risk modification
info
belief
motivation
behavioural change
ACE inhibitors - name
-pril
ACE inhibitors - mechanism of action
reduce excess water and salt retention
reduce bp
inhibit AT1 to AT2 (vasoconstrictor) so reduce aldosterone
ACE inhibitors - SEs
cough
hypotension
angio-oedema
lichenoid reactions
AT2 blockers name
-artan
B-blockers - name
-olol
atenolol
selective (B1 only)
only on B-receptors in CV system
B-blockers - action
reduce heart muscle excitability
stop arrhythmias
reduce bp
prevent increase in hr